These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 17063521

  • 1. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S, Khulan J, Bissett SL, Ferns RB, Nymadawa P, Tedder RS.
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [Abstract] [Full Text] [Related]

  • 2. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F, Perez L, de Neira M, Hall AJ.
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
    Tsatsralt-Od B, Takahashi M, Endo K, Agiimaa D, Buyankhuu O, Ninomiya M, Lorenzo FR, Okamoto H.
    J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839
    [Abstract] [Full Text] [Related]

  • 4. Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants.
    Chang MH.
    Antivir Ther; 2010 Aug; 15(3 Pt B):463-9. PubMed ID: 20516566
    [Abstract] [Full Text] [Related]

  • 5. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
    Tabor E.
    J Med Virol; 2006 Aug; 78 Suppl 1():S43-7. PubMed ID: 16622882
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy.
    Mele A, Tancredi F, Romanò L, Giuseppone A, Colucci M, Sangiuolo A, Lecce R, Adamo B, Tosti ME, Taliani G, Zanetti AR.
    J Infect Dis; 2001 Oct 01; 184(7):905-8. PubMed ID: 11509998
    [Abstract] [Full Text] [Related]

  • 7. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
    Dong Y, Liu SL, Zhai XJ, Zhu FC, Pan H, Yu JX, Chen YZ, Xie YR, Zhang XY, Zhang HM, Li LJ, Wang H, Ruan B.
    J Med Virol; 2009 Sep 01; 81(9):1517-24. PubMed ID: 19626618
    [Abstract] [Full Text] [Related]

  • 8. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA, Teufel A, Kanzler S, Shrestha A, Victor A, Otto G, Lohse AW, Galle PR, Höhler T.
    Am J Gastroenterol; 2008 Jan 01; 103(1):138-46. PubMed ID: 17970833
    [Abstract] [Full Text] [Related]

  • 9. Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Aghasadeghi MR, Velayati AA, Mamishi S, Nabavi M, Aghakhani A, Bidari-Zerehpoosh F, Haghi Ashtiani MT, Sabeti S, Banifazl M, Azimian-Zavareh F, Motevalli F, Soleymani S, Ramezani A.
    Arch Virol; 2016 Dec 01; 161(12):3405-3411. PubMed ID: 27613286
    [Abstract] [Full Text] [Related]

  • 10. Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population.
    Ordög K, Szendrôi A, Szarka K, Kugler Z, Csire M, Kapusinszky B, Xie J, Csizmadia K, Brojnás J, Rusvai E, Tempfli A, Berencsi G.
    J Med Virol; 2003 Jun 01; 70(2):194-204. PubMed ID: 12696105
    [Abstract] [Full Text] [Related]

  • 11. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 01; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 12. [Respective importance of vertical and horizontal transmission of hepatitis B in the Australian archipelago (French Polynesia). Preliminary results of the vaccination of newborns].
    Boutin JP, Spiegel A, Flye Sainte-Marie F, Cartel JL, Girard M, Saliou P, Roux J.
    Bull Soc Pathol Exot; 1991 Feb 01; 84(5 Pt 5):906-11. PubMed ID: 1840244
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
    Basuni AA, Butterworth L, Cooksley G, Locarnini S, Carman WF.
    Vaccine; 2004 Jul 29; 22(21-22):2791-9. PubMed ID: 15246613
    [Abstract] [Full Text] [Related]

  • 14. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA, Delgado CA, Estévez ZC, Martínez JC, Ríos GV, Aureoles-Roselló SR, Zaldívar RA, Guzmán MA, Baile NF, Reyes PA, Ruano LO, Fernández AC, Lobaina-Matos Y, Fernández AD, Madrazo AI, Martínez MI, Baños ML, Alvarez NP, Baldo MD, Mestre RE, Pérez MV, Martínez ME, Escobar DA, Guanche MJ, Cáceres LM, Betancourt RS, Rando EH, Nieto GE, González VL, Rubido JC.
    Int J Infect Dis; 2007 Sep 29; 11(5):394-401. PubMed ID: 17257877
    [Abstract] [Full Text] [Related]

  • 15. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti, Pati NT, Sethi A, Agrawal K, Agrawal K, Kumar GT, Kumar M, Kaanan AT, Sarin SK.
    J Gastroenterol Hepatol; 2008 Nov 29; 23(11):1710-5. PubMed ID: 18761556
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization.
    Hipgrave DB, Nguyen TV, Vu MH, Hoang TL, Do TD, Tran NT, Jolley D, Maynard JE, Biggs BA.
    Am J Trop Med Hyg; 2003 Sep 29; 69(3):288-94. PubMed ID: 14628946
    [Abstract] [Full Text] [Related]

  • 17. Analysis of hepatitis B surface antigen mutations in Mongolia: molecular epidemiology and implications for mass vaccination.
    Davaalkham D, Ojima T, Uehara R, Watanabe M, Oki I, Endo K, Takahashi M, Okamoto H, Nakamura Y.
    Arch Virol; 2007 Sep 29; 152(3):575-84. PubMed ID: 17115304
    [Abstract] [Full Text] [Related]

  • 18. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD, Mashinter LD, Lindemulder A, Taylor GD, Chiu I.
    HIV Med; 2007 Jul 29; 8(5):295-9. PubMed ID: 17561875
    [Abstract] [Full Text] [Related]

  • 19. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J, Li RC, Yang JY, Li YP, Chen XR, Xu ZY, Liu CB, Cao HL, Zhao K, Ni DM.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr 29; 11(4):203-5. PubMed ID: 12716514
    [Abstract] [Full Text] [Related]

  • 20. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.
    Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, Chiang YM, Liu TT, Chen CL.
    J Med Virol; 2003 Apr 29; 69(4):471-4. PubMed ID: 12601753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.